Here, we found that METTL16 knockdown can decrease the proliferation, migration, invasion, and EMT of BC cells via regulating the FBXO5’s expression, and thereby restrain the growth and metastasis of BC in vivo, suggesting their potential as therapeutic targets for inhibiting BC progression and metastasis. The gene discussed is FBXO5; the disease is breast cancer.